5596
B. Jawabrah Al-Hourani et al. / Tetrahedron 64 (2008) 5590–5597
4.8.14. 5-Methyl-2-(3,4,5-trimethylpyrazol-1-yl)thiazole (12af)
and 5-methylene-2-(3,4,5-trimethylpyrazol-1-yl)-4,5-dihydro-
thiazole (13af)
Following the general procedure, thiazoles 12af (0.62 g,
3.00 mmol, 66%) and 13af (0.21 g, 1.00 mmol, 22%) were obtained
as white solids (recrystallization from n-hexane).
C) cmꢁ1. 1H NMR (CDCl3): d¼2.46 (s, 3H, Me), 3.44 (s, 3H, OMe), 4.44
(s, 2H, OCH2), 7.10 (d, 3J¼2.6 Hz, 1H, H-40), 7.25 (ddd, 3J¼7.7, 4.9 Hz,
4J¼1.3 Hz, 1H, H-5), 7.75 (ddd, 3J¼7.9, 7.7 Hz, 4J¼1.9 Hz, 1H, H-4),
8.06 (ddd, 3J¼7.9 Hz, 4J¼1.3 Hz, 5J¼1.0 Hz, 1H, H-3), 8.36 (d,
3J¼2.6 Hz, 1H, H-50), 8.64 (ddd, 3J¼4.9 Hz, 4J¼1.9 Hz, 5J¼1.0 Hz, 1H,
H-6). 13C NMR (CDCl3): d¼11.14 (q, 500-Me), 58.31 (q, OMe), 67.43 (t,
OCH2), 107.12 (d, C-40), 120.56 (d, C-3), 123.16 (d, C-5), 128.48 (d,
C-50), 128.68 (s), 136.64 (d, C-4), 145.47 (s), 149.37 (d, C-6), 150.96
(s), 154.20 (s), 157.58 (s), assignments by C–H shift correlation. Anal.
Calcd for C14H14N4OS (286.36): C, 58.72; H, 4.93; N, 19.57; S, 11.20.
Found: C, 58.49; H, 4.90; N, 19.42; S, 11.31.
Compound 12af. Mp: 82–83 ꢀC. IR (CDCl3): 1595 (C]C), 1449
(C]N), 1277 (S–C) cmꢁ1. 1H NMR (CDCl3): d¼1.94 (s, 3H, Me), 2.21
(s, 3H, Me), 2.40 (d, 4J¼1.3 Hz, 3H, Me), 2.55 (s, 3H, Me), 7.12 (q,
4J¼1.3 Hz, 1H, H-4). 13C NMR (CDCl3): d¼7.81 (q, Me), 11.77 (q, Me),
11.81 (q, Me), 12.02 (q, Me), 115.46 (s), 129.29 (s), 136.87 (d, C-4),
137.45 (s), 150.57 (s), 161.01 (s). Anal. Calcd for C10H13N3S (207.29):
C, 57.94; H, 6.32; N, 20.27; S, 15.47. Found: C, 57.73; H, 6.35; N,
19.96; S, 16.02.
Compound 13af. Mp: 72–73 ꢀC. IR (CDCl3): 1619 (C]C), 1432
(C]N), 1275 (S–C) cmꢁ1. 1H NMR (CDCl3): d¼1.91 (s, 3H, Me), 2.18
(s, 3H, Me), 2.46 (s, 3H, Me), 5.01 (t, 4J¼2.4 Hz, 2H), 5.21 (t, 4J¼2.4 Hz,
2H). 13C NMR (CDCl3): d¼7.73 (q, Me), 12.05 (q, Me), 12.10 (q, Me),
68.49 (t, C-4), 102.86 (t, ]CH2), 116.44 (s), 138.51 (s), 146.89 (s),
151.16 (s), 156.85 (s). Anal. Calcd for C10H13N3S (207.29): C, 57.94; H,
6.32; N, 20.27; S, 15.47. Found: C, 57.93; H, 6.25; N, 20.22; S, 15.59.
4.8.18. 1-(5-Methylthiazol-2-yl)-1H-benzimidazole (12ah)
Yield: 0.64 g (85%), brown crystals; mp: 88–90 ꢀC (from ace-
tone). 1H NMR (CDCl3): d¼2.44 (d, 4J¼1.2 Hz, 3H, CH3), 7.33 (q,
4J¼1.2 Hz, 1H, H-40), 7.35 (t, 3J¼7.5 Hz, 2H, 2ꢂ]CH), 7.81 (d,
3J¼7.5 Hz, 1H, ]CH), 7.97 (d, 3J¼7.5 Hz, 1H, ]CH), 8.43 (s, 1H, H-2).
13C NMR (CDCl3): d¼11.81 (q, CH3), 112.06 (d), 120.62 (d, C]CH),
123.70 (d, C]CH), 124.63 (d, C]CH), 130.17 (s), 131.59 (s), 137.29 (d,
C]CH), 140.81 (d, C]CH), 143.83 (s, C]C), 154.73 (s, C-20). Anal.
Calcd for C11H9N3S (215.28): C, 61.37; H, 4.21; N, 19.51; S, 14.90.
Found: C, 61.23; H, 4.05; N, 19.41; S, 15.39.
4.8.15. 4-Methoxymethyl-5-methyl-2-(3,4,5-trimethylpyrazol-1-
yl)thiazole (12df) and 4-methoxymethyl-5-methylene-2-(3,4,5-
trimethylpyrazol-1-yl)-4,5-dihydrothiazole (13df)
Following the general procedure, thiazoles 12df (0.44 g,
1.75 mmol, 39%) and 13df (0.52 g, 2.07 mmol, 46%) were obtained
as white solid (recrystallization from n-hexane) and colorless oil,
respectively.
Compound 12df. Mp: 79–80 ꢀC. IR (CDCl3): 1595 (C]C), 1431
(C]N), 1363 (S–C), 1084 (C–O–C) cmꢁ1. 1H NMR (CDCl3): d¼1.89 (s,
3H, Me), 2.17 (s, 3H, Me), 2.37 (s, 3H, Me), 2.53 (s, 3H, Me), 3.38 (s,
3H, OMe), 4.39 (s, 2H, OCH2). 13C NMR (CDCl3): d¼7.67 (q, Me),10.70
(q, Me), 11.67 (q, Me), 11.89 (q, Me), 57.94 (q, OMe), 67.55 (t, OCH2),
115.26 (s), 127.18 (s), 137.39 (s), 145.08 (s), 150.40 (s), 158.68 (s).
Anal. Calcd for C12H17N3OS (251.35): C, 57.19; H, 6.83; N, 16.76; S,
13.03. Found: C, 57.16; H, 6.66; N, 16.81; S, 12.85.
Compound 13df. IR (CDCl3): 1638 (C]C), 1431 (C]N), 1363
(S–C), 1120 (C–O–C) cmꢁ1. 1H NMR (CDCl3): d¼1.84 (s, 3H, Me), 2.11
(s, 3H, Me), 2.42 (s, 3H, Me), 3.37 (s, 3H, OMe), 3.50 (m, 2H, OCH2,
diastereotopic protons), 5.12 (m, 1H), 5.24 (m, 2H). 13C NMR
(CDCl3): d¼7.42 (q, Me), 11.74 (q, Me), 11.94 (q, Me), 59.15 (q, OMe),
75.91 (t, OCH2), 78.41 (d, C-4), 104.28 (t, ]CH2), 116.23 (s), 138.37
(s), 147.70 (s), 150.94 (s), 156.12 (s). Anal. Calcd for C12H17N3OS
(251.35): C, 57.19; H, 6.83; N, 16.76; S, 13.03. Found: C, 57.34; H,
6.82; N, 16.72; S, 12.67.
4.8.19. 1-(5-Methylthiazol-2-yl)-1H-benzimidazol-
2-ylamine (12ai)
Yield: 0.34 g (83%), yellow crystals; mp: 173–175 ꢀC (from
diethyl ether). 1H NMR (DMSO-d6): d¼2.53 (d, 4J¼1.2 Hz, 3H, CH3),
7.02 (t, 3J¼6.6 Hz, 1H, ]CH), 7.12 (t, 3J¼6.6 Hz, 1H, ]CH), 7.24 (d,
3J¼6.6 Hz, 1H, ]CH), 7.35 (br, 2H, NH2), 7.45 (q, 4J¼1.2 Hz, 1H, H-40),
7.49 (d, 3J¼6.6 Hz, 1H, ]CH). 13C NMR (DMSO-d6): d¼11.54 (q, CH3),
109.33 (d, ]CH), 115.83 (d, ]CH), 119.68 (d, ]CH), 123.24 (d,
]CH), 130.34 (s, C]C), 131.36 (s, C]C), 136.63 (d, ]CH), 142.95 (s,
C]C), 153.37 (s), 155.35 (s). Anal. Calcd for C11H10N4S (230.22): C,
57.38; H, 4.34; N, 24.33; S, 13.93. Found: C, 56.94; H, 4.30; N, 24.25;
S, 14.00.
4.8.20. 2-Ethyl-1-(5-methylthiazol-2-yl)-1H-benzimidazole (12aj)
Yield: 1.00 g (82%), yellow crystals; mp: 56–57 ꢀC (from ace-
tone). 1H NMR (CDCl3): d¼1.40 (t, 3J¼7.8 Hz, 3H, CH3), 2.57 (d,
4J¼1.2 Hz, 3H, CH3 at C-50), 3.07 (q, 3J¼7.8 Hz, 2H, CH2), 7.29 (t, 3J¼
5.8 Hz, 2H, 2ꢂ]CH), 7.46 (q, 4J¼1.2 Hz, 1H, H-40), 7.53 (d, 3J¼5.8 Hz,
1H, ]CH), 7.77 (d, 3J¼5.8 Hz, 1H, ]CH). 13C NMR (CDCl3): d¼11.62
(q, CH3),12.24 (q, CH3), 21.88 (t, ethyl CH2),110.46 (d, C]CH),119.34
(d, C]CH), 123.25 (d, C]CH), 123.42 (d, C]CH), 134.48 (s, C]C),
135.40 (s, C]C), 138.23 (d, C]CH), 142.25 (s, C]C), 153.85 (s),
156.29 (s). Anal. Calcd for C13H13N3S (207.30): C, 64.16; H, 5.38; N,
17.26; S, 13.28. Found: C, 63.70; H, 5.41; N, 17.20; S, 13.64.
4.8.16. 2-[1-(5-Methylthiazol-2-yl)-1H-pyrazol-3-yl]-
pyridine (12ag)
4.8.21. 2-Ethyl-1-(4-methoxymethyl-5-methylthiazol-2-yl)-1H-
benzimidazole (12dj) and 2-ethyl-1-(4-methoxymethyl-5-
methylene-4,5-dihydrothiazol-2-yl)-1H-benzimidazole (13dj)
Following the general procedure, thiazoles 12dj (0.60 g,
2.09 mmol, 76%) and 13dj (0.13 g, 0.45 mmol,17%) were obtained as
yellow oils.
Compound 12dj. IR (CDCl3): 1613 (C]C), 1453 (C]N), 1364
(S–C),1075 (C–O–C) cmꢁ1. 1H NMR (CDCl3): d¼1.30 (t, 3J¼7.8 Hz, 3H,
CH2CH3), 2.39 (s, 3H, Me-50), 2.95 (q, 3J¼7.8 Hz, 2H, CH2CH3), 3.32 (s,
3H, OMe), 4.41 (s, 2H, OCH2), 7.14 (m, 2H, 2ꢂAr–H), 7.45 (m, 1H,
Ar–H), 7.64 (m, 1H, Ar–H). 13C NMR (CDCl3): d¼10.86 (q, Me), 11.20
(q, Me), 21.56 (t, CH2CH3), 57.96 (q, OMe), 67.05 (t, OCH2), 110.19 (d),
118.94 (d), 122.80 (d), 123.00 (d), 131.86 (s), 134.72 (s), 141.95 (s),
146.30 (s), 151.45 (s), 155.78 (s). Anal. Calcd for C15H17N3OS
(287.38): C, 62.69; H, 5.96; N, 14.62; S, 11.16. Found: C, 62.50; H,
5.78; N, 14.60; S, 11.62.
Yield: 0.45 g (91%), white solid; mp: 124–125 ꢀC (from diethyl
ether). IR (CDCl3): 1550 (C]C),1422 (C]N),1261 (S–C) cmꢁ1.1H NMR
(CDCl3): d¼2.45 (d, 4J¼1.3 Hz, 3H, Me), 7.10 (d, 3J¼3.0 Hz, 1H, H-40),
7.18 (q, 4J¼1.3 Hz, 1H, H-400), 7.24 (ddd, 3J¼7.5, 4.8 Hz, 4J¼1.2 Hz, 1H,
H-5), 7.74 (ddd, 3J¼7.8, 7.5 Hz, 4J¼1.7 Hz, 1H, H-4), 8.07 (ddd,
3J¼7.8 Hz, 4J¼1.2 Hz, 5J¼1.0 Hz,1H, H-3), 8.31 (d, 3J¼3.0 Hz,1H, H-50),
8.64 (ddd, 3J¼4.8 Hz, 4J¼1.7 Hz, 5J¼1.0 Hz,1H, H-6). 13C NMR (CDCl3):
d¼11.99 (q, 500-Me), 107.14 (d, C-40), 120.51 (d, C-3), 123.13 (d, C-5),
128.22 (d, C-50),130.79 (s, C-500), 136.57 (d, C-4), 137.17 (d, C-400),149.40
(d, C-6), 151.00 (s), 154.21 (s), 159.43 (s), assignments by C–H shift
correlation. Anal. Calcd for C12H10N4S (242.30): C, 59.48; H, 4.14; N,
22.93; S, 13.38. Found: C, 59.15; H, 4.15; N, 23.12; S, 13.23.
4.8.17. 2-[1-(4-Methoxymethyl-5-methylthiazol-2-yl)-1H-pyrazol-
3-yl]pyridine (12dg)
Yield: 0.52 g (88%), white solid; mp: 108–109 ꢀC (from n-hex-
ane). IR (CDCl3): 1545 (C]C), 1404 (C]N), 1366 (S–C), 1086 (C–O–
Compound 13dj. IR (CDCl3): 1615 (C]C),1456 (C]N),1364 (S–C),
1073 (C–O–C) cmꢁ1
.
1H NMR (CDCl3): d¼1.43 (t, 3J¼7.8 Hz, 3H,